Therapeutic activation of endothelial sphingosine 1-phosphate receptor-1 by chaperone-bound S1P suppresses proliferative retinal vasculopathy
C. Niaudet, B. Jung, A. Kuo, S. Swendeman, E. Bull, T. Seno, R. Crocker, Z. Fu, L. E. H. Smith, T. Hla
The paper shows that activating endothelial S1PR1 with HDL-bound S1P or a Gi-biased agonist suppresses neovascular tufts in retinopathy models.
bioRxiv · Jun 14, 2022 · PreprintPathology